findmyKOL

Whitney Woodmansee, MD

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNone on fileNPI
RegionGainesville, FL · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2022findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Whitney Woodmansee is an Endocrinology/Metabolic physician. OpenAlex indexes 72 publications with 2,094 citations (h-index 27).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
72publications

Distinct works indexed by OpenAlex.

2,094citations

Total citations across indexed works.

27h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1600 SW Archer Rd # 100226
Gainesville, FL 326101865

Telephone

352-273-8656

Registry record last updated 17 Mar 2018.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    41.6%
    l-Thyroxine34.6%
    Levothyroxine Sodium72%Synthroid28%
    Part D45 patients
    Thyroid Hormone Synthesis Inhibitor2.9%
    Methimazole100%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    28.5%
    GLP-1 receptor agonist8.8%
    Ozempic100%
    Part D<11 patients
    Insulin Analog8.5%
    Lantus Solostar42%Novolog Flexpen38%Tresiba Flextouch U-10021%
    Part D<11 patients

    + 2 more classes in this area

  • Genitourinary & hormones

    12.2%
    Androgen12.2%
    Testosterone82%Testosterone Cypionate18%
    Part D<11 patients
Where care is delivered (Part B)24.6% facility · 75.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”